Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589822 · ClinicalTrials.gov registry record · Phase 2
The EVICEL® Gastrointestinal Study
A Phase 2 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 2
- Development phase
- 214
- Enrollment target
NCT01589822 is a Phase 2 study that has completed, run by Ethicon. The registered enrollment target is 214 participants.
The verdict
NCT01589822, a Phase 2 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 214 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to gastrointestinal (GI) surgery.
Interventions
- BIOLOGICAL EVICEL Fibrin Sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01589822
The ClinicalTrials.gov registry entry for NCT01589822 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EVICEL Fibrin Sealant is the first listed.
NCT01589822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01589822 about?
NCT01589822 is a clinical study titled "The EVICEL® Gastrointestinal Study". The purpose of this study is to evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to gastrointestinal (GI) surgery.
What is the current status of trial NCT01589822?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 214 participants. The study started on 2012-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01589822?
The interventions under investigation include: EVICEL Fibrin Sealant (BIOLOGICAL).
Who is sponsoring clinical trial NCT01589822?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.